SEC Form 4 · accession 0001062993-18-004212
Orgenesis Inc. · ORGS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
David Sidransky
Director
Period of report
Oct 22, 2018
Accepted (ET)
Oct 25, 2018 · 9:37 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001460602
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF1 | $5.99 | Oct 22, 2018 | A | 29,200 | A | — | Jul 16, 2023 | Common Stock | 29,200 | 29,200 | D |
Explanation of responses
- F1These options were awarded under the Issuer's 2017 Equity Incentive Plan to purchase shares of common stock of the Issuer and vest on the one year anniversary of the date of grant, subject to the non-employee director's continued service on the Board of Directors.
Remarks
Total amount of options include (i) options to purchase 12,500 shares of common stock for service on the Board of Directors which had not been granted in 2017, (ii) options to purchase 12,500 shares for the 2018 annual director stock option grant and (iii) options to purchase 4,200 shares of common stock for Board committee chairmanships.